Literature DB >> 15964370

Mortality while awaiting liver retransplantation: predictability of MELD scores.

K D S Watt1, T Menke, E Lyden, T M McCashland.   

Abstract

INTRODUCTION: Model for End-stage Liver Disease (MELD) scores at the time of listing on the transplant waiting list have been shown to accurately predict 3-month mortality in adults. There is no data assessing the accuracy of the MELD scores in predicting mortality of patients awaiting liver retransplantation. We sought to determine the outcome of patients listed for retransplantation at a single center and the accuracy of MELD scores in predicting mortality on the transplant waiting list.
METHODS: A retrospective review of adult patients at a single center listed for a second liver transplantation during the years 1993 to 2000. MELD scores and a concordance statistic were calculated at the time of initial listing and initial transplant as well as the time of relisting for a second transplant and at 2, 4, 6, 8, 12, and 24 weeks after relisting.
RESULTS: Of the 63 patients in the study, 43 (68%) received a second transplant, and 20 (32%) died while awaiting retransplantation. Of the patients receiving a second transplant, 13 (30%) died within 1 year of receiving the transplant. The most common cause of death on the waiting list was sepsis (50%), hepatorenal syndrome (20%), and multiorgan failure (10%), whereas the majority of deaths posttransplantation were sepsis-related (69%). At the time of relisting the c-statistic for MELD scores predicting death after 1 week on the waiting list was 0.78 (P = .007). After 3 months on the waiting list, the c-stat was largely unchanged (0.76, P = .04).
CONCLUSIONS: We have shown that MELD scores may predict mortality on the transplant waiting list for patients listed for a second transplant.

Entities:  

Mesh:

Year:  2005        PMID: 15964370     DOI: 10.1016/j.transproceed.2005.03.004

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Impact of MELD on waitlist outcome of retransplant candidates.

Authors:  H J Kim; J J Larson; Y S Lim; W R Kim; R A Pedersen; T M Therneau; C B Rosen
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

2.  Short- and long-term outcomes of third liver transplantation at single centre.

Authors:  Hideya Kamei; Mamoun Al-Basheer; Jeffrey Shum; Michael Bloch; Roberto Hernandez Alejandro; Vivian McAlister; William Wall; Douglas Quan
Journal:  Hepatol Int       Date:  2012-03-14       Impact factor: 6.047

3.  The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.

Authors:  Markus Casper; Martin Mengel; Christine Fuhrmann; Eva Herrmann; Beate Appenrodt; Peter Schiedermaier; Matthias Reichert; Tony Bruns; Cornelius Engelmann; Frank Grünhage; Frank Lammert
Journal:  Trials       Date:  2015-03-08       Impact factor: 2.279

4.  Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

Authors:  Mohammad A B Al-Freah; Carl Moran; Matthew R Foxton; Kosh Agarwal; Julia A Wendon; Nigel D Heaton; Michael A Heneghan
Journal:  World J Hepatol       Date:  2017-07-18

5.  Study of re-transplantation and prognosis in liver transplant center in Iran.

Authors:  Javad Salimi; Ali Jafarian; Nasir Fakhar; Alireza Ramandi; Mohamad Behzadi; Ali Moeni; Habib Dashti; Atabak Najafi; Mohammad Reza Shariat; Jalil Makarem; Abdolhamid Chavoshi Khamneh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.